Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS
· Delayed Price · Currency is USD
0.0275
-0.0043 (-13.52%)
At close: Jun 10, 2025
Petros Pharmaceuticals Employees
Petros Pharmaceuticals had 18 employees as of December 31, 2024. The number of employees decreased by 3 or -14.29% compared to the previous year.
Employees
18
Change (1Y)
-3
Growth (1Y)
-14.29%
Revenue / Employee
$284,002
Profits / Employee
-$1,647,846
Market Cap
990.89K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Petros Pharmaceuticals News
- 20 days ago - Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets - Accesswire
- 21 days ago - Petros Pharmaceuticals partners with Innolitics to accelerate SaaS platform development - Seeking Alpha
- 21 days ago - Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer - Accesswire
- 5 weeks ago - Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform - Accesswire
- 5 weeks ago - Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches - Accesswire
- 6 weeks ago - Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms - Accesswire
- 2 months ago - Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications - Accesswire
- 3 months ago - Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study - Accesswire